Table 1.
Groups | n | Gender | Age | Clinical stage | |||
---|---|---|---|---|---|---|---|
Male | Female | Range | Mean age | IIIB | IV | ||
Control group | 60 | 33 | 27 | 42–71 | 50.45 ± 5.68 | 42 | 18 |
Experimental group | 60 | 31 | 29 | 40–72 | 50.18 ± 5.94 | 37 | 23 |
t value | — | 0.251 | |||||
P value | — | 0.802 |
Groups | n | Gender | Age | Clinical stage | |||
---|---|---|---|---|---|---|---|
Male | Female | Range | Mean age | IIIB | IV | ||
Control group | 60 | 33 | 27 | 42–71 | 50.45 ± 5.68 | 42 | 18 |
Experimental group | 60 | 31 | 29 | 40–72 | 50.18 ± 5.94 | 37 | 23 |
t value | — | 0.251 | |||||
P value | — | 0.802 |